ADAMs family in kidney physiology and pathology
Authors:
Open Access
- 12 October 2021
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 72, 103628
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81770674)
- Zhejiang Province Science and Technology Department (2020C03034)
- Primary Research and Development Plan of Zhejiang Province
This publication has 84 references indexed in Scilit:
- Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 ExcretionPLOS ONE, 2013
- Central role of the exchange factor GEF-H1 in TNF-α–induced sequential activation of Rac, ADAM17/TACE, and RhoA in tubular epithelial cellsMolecular Biology of the Cell, 2013
- Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplayEMBO Molecular Medicine, 2013
- Bradykinin Decreases Podocyte Permeability through ADAM17-Dependent Epidermal Growth Factor Receptor Activation and Zonula Occludens-1 RearrangementThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortalityThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseasesJournal of Biomedical Science, 2010
- CXCL16 Is Expressed in Podocytes and Acts as a Scavenger Receptor for Oxidized Low-Density LipoproteinThe American Journal of Pathology, 2009
- The Pathogenic Role of Notch Activation in PodocytesNephron Experimental Nephrology, 2009
- Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C‐shaped scaffoldThe EMBO Journal, 2006
- The Role of ADAM 15 in Glomerular Mesangial Cell MigrationJournal of Biological Chemistry, 2002